The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among different analogs, the specific sequence of silk and elastin units enables SELP-815K to act as a thermoresponsive polymer that is liquid at room temperature and forms a hydrogel at body temperature [41,43,44,45,46,48].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Research works printed but not linked: 28
- Center, 2011, International trends in liver cancer incidence rates, Cancer Epidemiol Biomarkers Prev, 20, 2362, 10.1158/1055-9965.EPI-11-0643 · DOI · Paper page
- Montella, 2010, Latest developments in targeted therapy for hepatocellular carcinoma, Expert Rev Anticancer Ther, 10, 1635, 10.1586/era.10.146 · DOI
- Brown, 2012, Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy, J Vasc Interventional Radiology, 23, 287, 10.1016/j.jvir.2011.11.029 · DOI · Paper page
- Forner, 2012, Hepatocellular carcinoma, Lancet, 379, 1245, 10.1016/S0140-6736(11)61347-0 · DOI · Paper page
- Bruix, 2005, Management of hepatocellular carcinoma, Hepatology, 42, 1208, 10.1002/hep.20933 · DOI · Paper page
- Hernandez-Gea, 2013, Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma, Gastroenterology, 144, 512, 10.1053/j.gastro.2013.01.002 · DOI · Paper page
- Llovet, 2003, Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival, Hepatology, 37, 429, 10.1053/jhep.2003.50047 · DOI · Paper page
- Dufour, 2013, Intermediate hepatocellular carcinoma: current treatments and future perspectives, Ann Oncol, 24, 24, 10.1093/annonc/mdt054 · DOI
- Altekruse, 2009, Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005, J Clin Oncol, 27, 1485, 10.1200/JCO.2008.20.7753 · DOI · Paper page
- Lewis, 2012, Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy, J Control Release, 161, 338, 10.1016/j.jconrel.2012.01.018 · DOI
- Tam, 2011, Chemoembolization agents for cancer treatment, Eur J Pharm Sci, 44, 1, 10.1016/j.ejps.2011.06.013 · doi:10.1016/j.ejps.2011.06.013
- Barkey, 2011, Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand, J Med Chem, 54, 8078, 10.1021/jm201226w · DOI
- Bruix, 2011, Management of hepatocellular carcinoma: an update, Hepatology, 53, 1020, 10.1002/hep.24199 · DOI · Paper page
- Bruix, 2010, Two decades of advances in hepatocellular carcinoma research, Seminars Liver Dis, 30, 1, 10.1055/s-0030-1247219 · DOI
- Laurent, 2007, Microspheres and nonspherical particles for embolization, Tech Vasc Interventional Radiology, 10, 248, 10.1053/j.tvir.2008.03.010 · doi:10.1053/j.tvir.2008.03.010
- Cappello, 1990, Genetic engineering of structural protein polymers, Biotechnol Prog, 6, 198, 10.1021/bp00003a006 · DOI · Paper page
- Cappello, 1998, In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs, J Control Release, 53, 105, 10.1016/S0168-3659(97)00243-5 · DOI · Paper page
- Cappello, 2002, Engineered protein polymers for drug delivery and biomedical applications, Adv Drug Deliv Rev, 54, 1053, 10.1016/S0169-409X(02)00057-1 · doi:10.1016/s0169-409x(02)00057-1
- Ghandehari, 2008, Recombinant biomaterials for pharmaceutical and biomedical applications, Pharm Res, 25, 672, 10.1007/s11095-007-9419-9 · doi:10.1007/s11095-007-9419-9
- Dandu, 2009, Silk–elastinlike protein polymer hydrogels: influence of monomer sequence on physicochemical properties, Polymer, 50, 366, 10.1016/j.polymer.2008.11.047 · DOI · Paper page
- Price, 2014, Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels, J Control Release, 195, 92, 10.1016/j.jconrel.2014.07.044 · DOI
- Barber, 2010, Biomimetic design of artificial micro-vasculatures for tissue engineering, Altern Laboratory Animals, 38, 67, 10.1177/026119291003801S02 · DOI
- Emerson, 2006, Biomimetic design of microfluidic manifolds based on a generalised murray's law, Lab a Chip, 6, 447, 10.1039/b516975e · DOI · Paper page
- Gaehtgens, 1970, Erythrocyte flow velocities in mesenteric microvessels of the cat, Microvasc Res, 2, 151, 10.1016/0026-2862(70)90003-8 · doi:10.1016/0026-2862(70)90003-8
- Price, 2012, Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery, Int J Pharm, 427, 97, 10.1016/j.ijpharm.2011.09.037 · DOI
- Lencioni, 2012, Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded dc bead (debdox): technical recommendations, Cardiovasc Interventional Radiology, 35, 980, 10.1007/s00270-011-0287-7 · DOI · Paper page
- Clark, 2006, Complications of hepatic chemoembolization, Seminars Interventional Radiology: Thieme Med Publ, 119, 10.1055/s-2006-941442 · doi:10.1055/s-2006-941442
- Brown KT. Fatal pulmonary complications after arterial embolization with 40–120-μm tris-acryl gelatin microspheres. Journal of Vascular and Interventional Radiology. 15:197-200. · doi:10.1097/01.rvi.0000109400.52762.1f
Cited by
Silk protein-based hydrogels: Promising advanced materials for biomedical applications
Kapoor, S., & Kundu, S. C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.034 · Cited by 500
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Advances in Biomaterials and Technologies for Vascular Embolization
Hu, J., Albadawi, H., Chong, B. W., Deipolyi, A. R., Sheth, R. A., Khademhosseini, A., & Oklu, R. (2019) · Advanced Materials · doi:10.1002/adma.201901071 · Cited by 321
Biomedical Applications of Recombinant Silk‐Based Materials
Aigner, T. B., DeSimone, E., & Scheibel, T. (2018) · Advanced Materials · doi:10.1002/adma.201704636 · Cited by 318
Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102426 · Cited by 20
Self-citation
Metadata
- Authors
- Poursaid, A., Price, R., Tiede, A., Olson, E., Huo, E., McGill, L., Ghandehari, H., & Cappello, J.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 57
- Pages
- 142-152
- ISSN
- 0142-9612
- Cited by
- 62
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- NIH grants (R41 CA168123, RO1 CA107621, F30 CA176922)
- Nanotechnology Training Program, University of Utah
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization. https://app.cochat.ai/papers/10.1016/j.biomaterials.2015.04.015
- The paper
- Poursaid, A., Price, R., Tiede, A., Olson, E., Huo, E., McGill, L., Ghandehari, H., & Cappello, J. (2015). In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization. Biomaterials. https://doi.org/10.1016/j.biomaterials.2015.04.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.